Budget impact analysis of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA.

CONCLUSION: As market shares of atypical antipsychotics are predicted to increase, payers may wish to re-evaluate their use. PMID: 29694243 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research